For example, in glioma, overexpression ofTUG1 could suppress the tumorigenicity of temozolomide resistance by downregulating the expression of EZH2 and promoting apoptosisvia an intrinsic pathway facilitated by caspase-3 and caspase-9[15–16]. Here, EZH2 is linked to central nervous system cancer.